Intellia Therapeutics, Inc. (NTLA)
8.99
-0.07
(-0.77%)
USD |
NASDAQ |
Dec 31, 16:00
9.02
+0.03
(+0.33%)
Pre-Market: 20:00
Intellia Therapeutics Research and Development Expense (TTM): 407.11M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| ANI Pharmaceuticals, Inc. | 56.05M |
| Regeneron Pharmaceuticals, Inc. | 5.097B |
| Beam Therapeutics, Inc. | 411.79M |
| Vertex Pharmaceuticals, Inc. | 3.954B |
| Pacific Biosciences of California, Inc. | 99.79M |